2026年,宫癌治疗的新进展
Alice Muzzarelli1, Mariachiara Paderno2, Domenica Lorusso2,3
1Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and Verona University and Hospital Trust (AOUI), Verona.
宫癌治疗的进步包括免疫疗法,抗血管生成药物和向疗法. 这些创新为患有晚期或复发性疾病的患者提供了新的希望,改善了全球的生存率和治疗结果.
科学领域:
- 在瘤学瘤学.
- 妇科瘤学 妇科瘤学
- 癌症研究 癌症研究
背景情况:
- 宫癌是全球主要的健康挑战,特别是在资源较低的环境中,预防和查的机会有限.
- 晚期或复发的宫癌历来有着不良的预后,尽管有手术或化疗等可用的治疗方法.
研究的目的:
- 审查最近宫癌治疗领域的进展.
- 突出新兴疗法及其对患者生存和治疗策略的影响.
主要方法:
- 审查最近的临床试验和宫癌治疗的治疗发展.
- 对新型药物的分析,包括免疫疗法,抗血管原药物和抗体-药物合物.
主要成果:
- 贝瓦西祖马布与化疗相结合,改善了宫癌的存活率.
- 免疫检查点抑制剂 (pembrolizumab,cemiplimab) 在各种治疗环境中显示出显著的益处.
- 布罗利祖马布与化疗放射疗法一起,在局部晚期疾病中显示出更高的存活率.
- 像tisotumab vedotin这样的抗体药物结合剂在复发性/转移性子宫癌中表现有前途.
结论:
- 治疗正在转向精准医学,整合免疫疗法,抗血管原和向药物.
- 挑战包括优化治疗序列,克服耐药性和识别预测生物标志物.
- 必须解决预防和治疗的全球差异,以实现世卫组织的消除目标.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
